Clinical and Radiologic Responses to Cladribine for the Treatment of Erdheim-Chester Disease

IMPORTANCE: While cladribine is best known for the treatment of hairy cell leukemia and other lymphoid cancers, it also has activity against myeloid neoplasms, such as Erdheim-Chester disease (ECD). OBJECTIVE: To assess the efficacy of cladribine (2-chloro-2′-deoxyadenosine) in the treatment of ECD....

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:JAMA Oncol
Autors principals: Goyal, Gaurav, Shah, Mithun V., Call, Timothy G., Litzow, Mark R., Hogan, William J., Go, Ronald S.
Format: Artigo
Idioma:Inglês
Publicat: American Medical Association 2017
Matèries:
Brief Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5824289/
https://ncbi.nlm.nih.gov/pubmed/28253394
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2017.0041
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars